SARAH MOHR: Open Payments
NPI 1730499070 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,064 in 53 payments from 15 companies in 2025. Trend: 2023 $1,137 · 2024 $1,490 · 2025 $1,064
Food & beverage: $1,064
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $221 |
| Lilly USA, LLC | 9 | $192 |
| PFIZER INC. | 9 | $173 |
| AstraZeneca Pharmaceuticals LP | 6 | $121 |
| Exact Sciences Corporation | 4 | $67 |
| ABBVIE INC. | 4 | $63 |
| Dexcom, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Astellas Pharma US Inc | 1 | $25 |
| Almatica Pharma LLC | 1 | $24 |
Products named: Ozempic, MOUNJARO, The Cologuard Plus Collection Kit, AIRSUPRA, NURTEC ODT, Dexcom G6 Transmitter, BREZTRI, JARDIANCE.
Industry payments across MD — which companies pay providers there.
